Lawrence Hayward to Bevacizumab
This is a "connection" page, showing publications Lawrence Hayward has written about Bevacizumab.
Connection Strength
0.137
-
Ali HR, Dariush A, Thomas J, Provenzano E, Dunn J, Hiller L, Vallier AL, Abraham J, Piper T, Bartlett JMS, Cameron DA, Hayward L, Brenton JD, Pharoah PDP, Irwin MJ, Walton NA, Earl HM, Caldas C. Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. Ann Oncol. 2017 Aug 01; 28(8):1832-1835.
Score: 0.137